SEGMENT REPORTING, GEOGRAPHICAL INFORMATION

12 Months Ended

Dec. 31, 2022

Segment Reporting [Abstract]

SEGMENT REPORTING, GEOGRAPHICAL INFORMATION

7. SEGMENT REPORTING, GEOGRAPHICAL INFORMATION

(a) Business segments

The Company operates in two business segments: Vycor Medical, which focuses on devices for neurosurgery; and NovaVision, which focuses on neuro stimulation therapies and diagnostic devices for the treatment and screening of vision field loss. Discontinued operations were part of NovaVision and revenues and assets were in Europe; see Note 3. Set out below are the revenues, gross profits and total assets for each segment.

	Year Ended December 31,
	2022		2021
Revenue:
Vycor Medical	$	1,130,915	$	1,273,602
NovaVision	$	92,074	$	119,385
	$	1,222,989	$	1,392,987
Gross Profit
Vycor Medical	$	997,667	$	1,147,574
NovaVision	$	84,678	$	110,685
	$	1,082,345	$	1,258,259

	December 31,		December 31,
	2022		2021
Total Assets:
Vycor Medical	$	822,174	$	901,930
NovaVision		36,792		33,054
Discontinued operations		1,212		380
Total Assets	$	860,178	$	935,364

(b) Geographic information. The Company operates in two geographic segments, the United States and Europe. Discontinued operations were part of NovaVision and revenues and assets were in Europe; see Note 3. Set out below are the revenues, gross profits and total assets for each segment.

	Year Ended December 31,
	2022		2021
Revenue:
United States	$	1,214,723	$	1,374,770
Europe	$	8,266	$	18,217
	$	1,222,989	$	1,392,987
Gross Profit
United States	$	1,074,143	$	1,240,305
Europe	$	8,202	$	17,954
	$	1,082,345	$	1,258,259

	December 31,		December 31,
	2022		2021
Total Assets:
United States	$	854,236	$	928,761
Europe		4,730		6,223
Discontinued operations		1,212		380
Total Assets	$	860,178	$	935,364